338 related articles for article (PubMed ID: 33791919)
1. LncRNA TUG1 exhibits pro-fibrosis activity in hypertrophic scar through TAK1/YAP/TAZ pathway via miR-27b-3p.
Li XM; Yu WY; Chen Q; Zhuang HR; Gao SY; Zhao TL
Mol Cell Biochem; 2021 Aug; 476(8):3009-3020. PubMed ID: 33791919
[TBL] [Abstract][Full Text] [Related]
2. Silencing of long noncoding INHBA antisense RNA1 suppresses proliferation, migration, and extracellular matrix deposition in human hypertrophic scar fibroblasts via regulating microRNA-141-3p/myeloid cell leukemia 1 axis.
Yang Y; Xiao C; Liu K; Song L; Zhang Y; Dong B
Bioengineered; 2021 Dec; 12(1):1663-1675. PubMed ID: 33977869
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA H19 promotes the proliferation, migration and invasion while inhibits apoptosis of hypertrophic scarring fibroblasts by targeting miR-3187-3p/GAB1 axis.
Xiao M; Zou X; Li B; Zhang B
Burns; 2021 May; 47(3):654-664. PubMed ID: 32888745
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
Tang Y; Yang P; Zhu Y; Su Y
Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
[TBL] [Abstract][Full Text] [Related]
5. MiR-3613-3p inhibits hypertrophic scar formation by down-regulating arginine and glutamate-rich 1.
Li L; Han W; Chen Y; Chen Y
Mol Cell Biochem; 2021 Feb; 476(2):1025-1036. PubMed ID: 33165823
[TBL] [Abstract][Full Text] [Related]
6. Silencing of the lncRNA
Zhang B; Zhao C; Hou L; Wu Y
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MIR503HG promotes hypertrophic scar progression via miR-143-3p-mediated Smad3 expression.
Wei J; Wang Z; Zhong C; Ding H; Wang X; Lu S
Wound Repair Regen; 2021 Sep; 29(5):792-800. PubMed ID: 33819360
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
Xu K; Zhang L
Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
[TBL] [Abstract][Full Text] [Related]
11. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
Liu Z; Guo N; Zhang XJ
Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis.
Zhang X; Yang L; Xu G
Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) regulates fibroblast growth factor receptor substrate 2 (FRS2) by targeting microRNA (miR)-29-3p in hypertrophic scar fibroblasts.
Wu Q; Chen J; Tan Z; Wang D; Zhou J; Li D; Cen Y
Bioengineered; 2021 Dec; 12(1):5210-5219. PubMed ID: 34414852
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
Mu S; Kang B; Zeng W; Sun Y; Yang F
Mol Cell Biochem; 2016 May; 416(1-2):99-108. PubMed ID: 27075467
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy.
Su Q; Liu Y; Lv XW; Ye ZL; Sun YH; Kong BH; Qin ZB
J Mol Cell Cardiol; 2019 Aug; 133():12-25. PubMed ID: 31145943
[TBL] [Abstract][Full Text] [Related]
19. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.
Zhang B; Sun YF; Zhang XM; Jiang N; Chen Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4940-4953. PubMed ID: 32432757
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis.
Su Q; Liu Y; Lv XW; Dai RX; Yang XH; Kong BH
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H332-H344. PubMed ID: 31858814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
